New Turkey Drug Pricing Regulation: 2026 Euro Rate Up 17%
Türkiye Introduces New Pharmaceutical Pricing Regulation
Türkiye has introduced a new regulation affecting the pricing of pharmaceutical products, following a presidential decree published in the Official Gazette (Resmi Gazete).
Under the new decision, the base euro exchange rate used in the pricing of medicines for 2026 has been increased by approximately 17%. The adjustment directly impacts how drug prices are calculated within the national pricing system.
Key Financial Parameters of the Decree
According to the decree, the new financial parameters are set as follows:
- New Base Exchange Rate: 25.3346 Turkish lira (compared to 21.6721 lira in 2025).
- Price Protection Threshold: Medicines covered by price protection will have a new threshold of 87.34 lira.
- General Medicine Threshold: Other medicines will be set at 45.64 lira.
Expected Impact and Implementation
The regulation is expected to enter into force imminently.
Experts note that the changes may lead to a gradual increase in medicine prices at pharmacies across the country.
This update to the pricing framework is a significant adjustment aimed at reflecting current economic conditions, with direct consequences for both the pharmaceutical industry and consumers.
